Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the appointment of Kelly Perez as Chief Financial Officer (CFO) and Senior Vice President of Operations, strengthening its leadership team as adoption of vMap accelerates.

“Kelly brings deep financial expertise, operational discipline, and healthcare experience that will be invaluable as Vektor continues to grow,” said Rob Krummen, Chief Executive Officer of Vektor Medical. “Her track record building strong organizations and guiding companies through growth positions Vektor to accelerate vMap adoption, expand our reach with physicians, and deliver improved outcomes for patients around the world.”

Perez will help guide Vektor’s financial strategy and operations to support the increasing adoption of vMap. A seasoned healthcare executive, she brings a strong record of scaling companies and leadership experience from roles at Omniome, Luxtera, and Sequenom.

“Joining Vektor at this inflection point is a tremendous opportunity,” said Perez. “vMap is a high-impact solution that is designed to improve patient outcomes without disrupting workflows, and I look forward to expanding operations and aligning financial strategy to support Vektor’s mission of advancing cardiac care in an efficient and sustainable way.”

Vektor’s core technology, vMap, is the only FDA-cleared, non-invasive arrhythmia analysis tool that uses a standard 12-lead ECG to localize both focal and fibrillation-type arrhythmias in all four chambers of the heart in under a minute. vMap is designed for broad adoption, with a recurring revenue model tied to procedure volume and the advantage of being a software-first solution. Its strong traction across leading health systems positions Vektor to expand collaborations with MedTech partners focused on improving outcomes and procedural efficiency.

“The Board is delighted to welcome Kelly to the executive team,” said Mike Monko, Chairman of the Board at Vektor Medical. “Her proven ability to scale organizations and navigate complex healthcare markets strengthens Vektor’s foundation for long-term success and impact in improving arrhythmia care. We are confident that her leadership will help guide the company through its next phase of expansion and deliver meaningful value to patients, providers, and partners.”

To learn more about Vektor Medical, vMap technology, visit www.vektormedical.com and connect on LinkedIn and X.

About Vektor Medical

Headquartered in San Diego, Vektor Medical is redefining how arrhythmias are understood and treated. The company developed vMap®, the only FDA-cleared, non-invasive technology that uses standard 12-lead ECG data to localize arrhythmia source locations across all four chambers of the heart. By helping physicians identify arrhythmia drivers more quickly and with greater accuracy, Vektor is improving outcomes, enhancing efficiencies, and accelerating access to effective treatment strategies. To learn more, visit www.vektormedical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250827600332/en/

Perez will help guide Vektor’s financial strategy and operations to support the increasing adoption of vMap.